Patents for C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897) |
---|
02/04/2004 | CN1137133C Preparation of sterol and dihydro-sterol ester |
01/29/2004 | WO2004009527A1 Materials and methods for treating hypercholesterolemia |
01/29/2004 | US20040019023 Administering 9,10-secopregna-5,7,10(19),16- tetraene derivative to a patient for treating skin diseases such as psoriasis |
01/29/2004 | CA2492906A1 Materials and methods for treating hypercholesterolemia |
01/28/2004 | EP1383492A1 Molecular conjugates for use in treatment of cancer |
01/27/2004 | US6683197 Process for the production of 4,4-dimethyl-5α-cholesta-8,14,24-trien-3β-01 and intermediate products in process (I) |
01/22/2004 | WO2004007521A2 Bile acid derivatives as agonists of the farnesoid x receptor |
01/22/2004 | US20040014734 Anticholesterol agents |
01/21/2004 | EP1382662A1 Sterol compositions, fat compositions containing the same and foods |
01/21/2004 | EP1381357A2 Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity |
01/21/2004 | EP0914165A4 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
01/21/2004 | CN1135234C Phytostrin and/or phytosteroidal alkanol derivative |
01/20/2004 | CA2123051C Nor-bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
01/15/2004 | US20040009958 Inhibiting hyperproliferation of malignant or neoplastic cells in acute lymphobalstic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia and plasma cell dyscrasias. |
01/14/2004 | EP1379254A1 Use of bile acid or bile salt fatty acid conjugates |
01/14/2004 | CN1468103A Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
01/13/2004 | US6677374 Nervous system disorders |
01/07/2004 | EP1150968B1 Method for producing phytosterols |
01/07/2004 | CN1133644C Simple synthesizing process for rapin lactones and the like |
01/06/2004 | US6673951 Process for catalytically hydrogenating phytosterols |
01/02/2004 | EP1373185A2 Hydrophobic polyamine analogs and methods for their use |
01/01/2004 | US20040002484 Novel steroidal antiestrogens and antiandrogens and uses thereof |
12/31/2003 | WO2004001002A2 Novel anticholesterol compositions and method for using same |
12/31/2003 | WO2004000869A1 Glucocorticoid receptor ligands for the treatment of metabolic disorders |
12/31/2003 | WO2004000857A1 Method of storing hydrogen, hydrogen inclusion compound and process for producing the same |
12/31/2003 | CA2489702A1 Novel anticholesterol compositions and method for using same |
12/30/2003 | US6670393 Carbamate-based cationic lipids |
12/30/2003 | CA2098146C Process for the preparation of 20-keto-21-alpha-hydroxy steroids and intermediates |
12/25/2003 | US20030236408 Estrogenic compounds as anti-mitotic agents |
12/24/2003 | CN1131871C Prepn. of sterol ester and steriod esters |
12/18/2003 | WO2002090375A3 Liver x receptor agonists |
12/11/2003 | WO2002053149A3 Medicament containing a polyamine as an active substance |
12/11/2003 | US20030229037 Novel cationic amphiphiles |
12/10/2003 | EP1077992B1 Use of meiosis regulating compounds |
12/09/2003 | CA2150233C Process for producing provitamin d compound |
12/03/2003 | CN1129602C 11-(substituted phenyl) estra-4,9-diene derivatives |
12/02/2003 | CA2118565C Process for the preparation of 3.beta.-aminocholanic acid derivatives |
11/27/2003 | WO2002062302A3 Steroidal derivatives |
11/26/2003 | EP1169335B1 Method for producing phytosterols from reduced quantities of methanol by crystallization |
11/26/2003 | CN1458918A Method for preparing fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
11/26/2003 | CN1458163A Oriental waterplantain rhizome sterol extract and its preparing method and quality control method |
11/25/2003 | US6653492 Preparation of bile acids |
11/25/2003 | US6653491 Method for producing 4,4-dimethyl-3β-hydroxypregna-8, 14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
11/20/2003 | WO2003095470A1 Platinum complexes having antitumor activity |
11/20/2003 | CA2485431A1 Platinum complexes having antitumor activity |
11/19/2003 | EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
11/19/2003 | EP0857173B1 Meiosis regulating compounds |
11/13/2003 | US20030212045 Cosalane compounds and methods for their use |
11/12/2003 | CN1455667A Use of an epoxy-sterodal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects |
11/12/2003 | CN1454598A Compound phytosterol with serum cholesterol-reducing action and preparing process thereof |
11/12/2003 | CN1127509C Process for hydrogenating unsaturated plant-based compounds and regeneration of used catalyst |
11/11/2003 | US6645955 3,6-dihydroxy-24-amidyl steroid derivatives |
11/11/2003 | US6645953 Meiosis regulating compounds |
11/06/2003 | WO2003090547A1 A composition comprising waxy acids for effecting serum cholesterol levels |
10/30/2003 | US20030203854 Composition for effecting serum cholesterol levels |
10/29/2003 | CN1452630A Substd. sapogenins and their use |
10/28/2003 | CA2269897C Aminophenol derivatives and their use in cosmetics |
10/23/2003 | WO2003087121A1 Branched polyamine steroid derivatives |
10/23/2003 | WO2003086303A2 Farnesoid x-activated receptor agonists |
10/23/2003 | CA2482195A1 Farnesoid x-activated receptor agonists |
10/23/2003 | CA2479714A1 Branched polyamine steroid derivatives |
10/22/2003 | CN1450079A Crosslinking monomer containing bile acid and preparation process and use thereof |
10/21/2003 | US6635774 Catalyst-free direct esterification of stanols and sterols with fatty acids to form stanol/sterol-esters. |
10/16/2003 | US20030195367 Method for preparing a fatty substance ester and use thereof in pharmaceutics, cosmetics or food industry |
10/15/2003 | CN1448400A Synthetic method of 24-methylene-cholesterol-3 beta, 5 alpha, 6 beta,19-tetraalcohol |
10/15/2003 | CN1448399A Synthetic method of 24-methylene-cholesterol-5-alkenyl-3 beta, 19-glycol |
10/15/2003 | CN1124280C Novel monomer and polymer for photoresist, and photoresist using the same |
10/09/2003 | US20030191102 Contraception method using competitive progesterone antagonists and novel compounds useful therein |
10/08/2003 | EP1349909A1 A process for the preparation of a fat composition containing sterol esters a product obtained by said process and the use thereof |
10/07/2003 | US6630503 Cell adhesion inhibitors |
10/02/2003 | WO2003080778A2 Methods for treating deodorizer distillate |
10/02/2003 | WO2003079998A2 Treatment of diseases involving defective gap junctional communication |
10/02/2003 | WO2003064442A3 Distalliative process of extracting and purifying phytosterols and phytostanols from tall oil pitch |
10/02/2003 | US20030187276 Hydrophobic polyamine analogs and methods for their use |
10/02/2003 | CA2479773A1 Methods for treating deodorizer distillate |
10/02/2003 | CA2479555A1 Use of cocoa flavanols and oligomers thereof to treat cognitive dysfunction and improve cognitive function in neuro-compromised patients |
09/30/2003 | US6627245 Stable homogeneous emulsifier-free suspension, preparation method and uses in food compositions |
09/30/2003 | US6627218 Cationic lipid with a lipophilic group derived from cholesterol; an amide or carbamate linker bond; an alkylene spacer arm; and a cationic primary, secondary, tertiary or quaternary amino group. facilitating nucleic acid transfer |
09/25/2003 | WO2003077869A2 Neuroprotective spirostenol pharmaceutical compositions |
09/25/2003 | US20030181742 Process for the preparation of pregnane derivatives |
09/25/2003 | US20030181662 Human procalcitonin and the preparation and use thereof |
09/25/2003 | US20030180406 Treatment of diseases involving defective gap junctional communication |
09/25/2003 | CA2479249A1 Neuroprotective spirostenol pharmaceutical compositions |
09/24/2003 | CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
09/24/2003 | CN1443771A Syntehsis method plant sterol or/and plant steroid alkanol-beta-D-glucoside compound |
09/23/2003 | US6624156 Methods of making and method of using hybrid cholinergic agents and compositions |
09/23/2003 | US6624155 Hybrid cholinergic agents and compositions |
09/17/2003 | EP1343803A2 2-substituted estrogens as antiangiogenic agents |
09/17/2003 | EP1343485A2 Lipid-based nitric oxide donors |
09/17/2003 | EP1070082B1 Method for producing 4,4-dimethyl-5alpha-cholesta-8,14,24-triene-3beta-ol and intermediate products obtained by said method |
09/17/2003 | CN1443193A Crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
09/17/2003 | CN1442425A Adjuvent DC-chol, its liposome, preparation method and its use |
09/17/2003 | CN1442199A Composition for improving intestine and gastric action |
09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
09/11/2003 | US20030171576 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone. |
09/10/2003 | CN1440978A Pyloric spirobacterium inhibitor |
09/03/2003 | EP0767798B1 Sterol derivatives used for regulation of meiosis |
09/03/2003 | CN1120171C Medicinal use of total sterone in radix rhapontici and preparing method thereof |
08/28/2003 | US20030162701 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
08/27/2003 | EP1173463B1 Process for the purification of sterols from hydrocarbon extracts using evaporative fractionation |